marijuana stocks

Form 8-K for LEXARIA CORP.


24-Aug-2015

Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure.A copy of the news release announcing the Company’s technology achieves Cannabidiol absorption rate 499% greater than baseline in laboratory testing filed as exhibit 99.1 to this current report and is hereby incorporated by reference.

 


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Canopy Growth Corporation (CGC) CEO David Klein and Wana Cofounder & CEO Nancy Whiteman to Keynote At Benzinga Cannabis Capital Conference

Canopy Growth CEO David Klein and Wana Cofounder & CEO Nancy Whiteman…

$EAPH Announces First Shipment of Gynofit

Easton Pharmaceuticals and BMV Medica Announces First Shipment of Gynofit To Multi-National…

Aphria, Inc. (APHA) to Host Earnings Call

Aphria, Inc. to Host Earnings Call Aphria, Inc. (APHA) will be discussing…

$Oxis Biotech Inc. Announces Corporate Update Conference Call for March 31

TAMPA, Fla., March 25, 2015 /PRNewswire/ — Oxis International, Inc. (OXIS) (OXI.PA)…